Dissecting Causal Relationships Between Gut Microbiota, Blood Metabolites, and Stroke: A Mendelian Randomization Study
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose We investigated the causal relationships between the gut microbiota (GM), stroke, and potential metabolite mediators using Mendelian randomization (MR). Methods We leveraged the summary statistics of GM (n=18,340 in the MiBioGen consortium), blood metabolites (n=115,078 in the UK Biobank), and stroke (cases n=60,176 and controls n=1,310,725 in the Global Biobank Meta-Analysis Initiative) from the largest genome-wide association studies to date. We performed bidirectional MR analyses to explore the causal relationships between the GM and stroke, and two mediation analyses, two-step MR and multivariable MR, to discover potential mediating metabolites. Results Ten taxa were causally associated with stroke, and stroke led to changes in 27 taxa. In the two-step MR, <i>Bifidobacteriales</i> order, <i>Bifidobacteriaceae</i> family, <i>Desulfovibrio</i> genus, apolipoprotein A1 (ApoA1), phospholipids in high-density lipoprotein (HDL_PL), and the ratio of apolipoprotein B to ApoA1 (ApoB/ApoA1) were causally associated with stroke (all <i>P</i><0.044). The causal associations between <i>Bifidobacteriales</i> order, <i>Bifidobacteriaceae</i> family and stroke were validated using the weighted median method in an independent cohort. The three GM taxa were all positively associated with ApoA1 and HDL_PL, whereas <i>Desulfovibrio</i> genus was negatively associated with ApoB/ApoA1 (all <i>P</i><0.010). Additionally, the causal associations between the three GM taxa and ApoA1 remained significant after correcting for the false discovery rate (all q-values <0.027). Multivariable MR showed that the associations between <i>Bifidobacteriales</i> order, <i>Bifidobacteriaceae</i> family and stroke were mediated by ApoA1 and HDL_PL, each accounting for 6.5% (<i>P</i>=0.028) and 4.6% (<i>P</i>=0.033); the association between <i>Desulfovibrio</i> genus and stroke was mediated by ApoA1, HDL_PL, and ApoB/ApoA1, with mediated proportions of 7.6% (<i>P</i>=0.019), 4.2% (<i>P</i>=0.035), and 9.1% (<i>P</i>=0.013), respectively. Conclusion The current MR study provides evidence supporting the causal relationships between several specific GM taxa and stroke and potential mediating metabolites.
Abstract
Background and Purpose We investigated the causal relationships between the gut microbiota (GM), stroke, and potential metabolite mediators using Mendelian randomization (MR). Methods We leveraged the summary statistics of GM (n=18,340 in the MiBioGen consortium), blood metabolites (n=115,078 in the UK Biobank), and stroke (cases n=60,176 and controls n=1,310,725 in the Global Biobank Meta-Analysis Initiative) from the largest genome-wide association studies to date. We performed bidirectional MR analyses to explore the causal relationships between the GM and stroke, and two mediation analyses, two-step MR and multivariable MR, to discover potential mediating metabolites. Results Ten taxa were causally associated with stroke, and stroke led to changes in 27 taxa. In the two-step MR, <i>Bifidobacteriales</i> order, <i>Bifidobacteriaceae</i> family, <i>Desulfovibrio</i> genus, apolipoprotein A1 (ApoA1), phospholipids in high-density lipoprotein (HDL_PL), and the ratio of apolipoprotein B to ApoA1 (ApoB/ApoA1) were causally associated with stroke (all <i>P</i><0.044). The causal associations between <i>Bifidobacteriales</i> order, <i>Bifidobacteriaceae</i> family and stroke were validated using the weighted median method in an independent cohort. The three GM taxa were all positively associated with ApoA1 and HDL_PL, whereas <i>Desulfovibrio</i> genus was negatively associated with ApoB/ApoA1 (all <i>P</i><0.010). Additionally, the causal associations between the three GM taxa and ApoA1 remained significant after correcting for the false discovery rate (all q-values <0.027). Multivariable MR showed that the associations between <i>Bifidobacteriales</i> order, <i>Bifidobacteriaceae</i> family and stroke were mediated by ApoA1 and HDL_PL, each accounting for 6.5% (<i>P</i>=0.028) and 4.6% (<i>P</i>=0.033); the association between <i>Desulfovibrio</i> genus and stroke was mediated by ApoA1, HDL_PL, and ApoB/ApoA1, with mediated proportions of 7.6% (<i>P</i>=0.019), 4.2% (<i>P</i>=0.035), and 9.1% (<i>P</i>=0.013), respectively. Conclusion The current MR study provides evidence supporting the causal relationships between several specific GM taxa and stroke and potential mediating metabolites.
참고문헌 (45)
- Tsao CW, "Heart disease and stroke statistics-2022update : a report from the American Heart Association", Circulation, 145, pp.e153~e639 (2022)
- Feigin VL, "Global burden of stroke", Circ Res, 120, pp.439~448 (2017)
- Nicholson JK, "Host-gut microbiota metabolic interactions", Science, 336, pp.1262~1267 (2012)
- Honarpisheh P, "Aging microbiotagut-brain axis in stroke risk and outcome", Circ Res, 130, pp.1112~1144 (2022)
- Xu K, "Rapid gut dysbiosis induced by stroke exacerbates brain infarction in turn", Gut, 70, pp.1486~1494 (2021)
- Winek K, "Role of the gut microbiota in ischemic stroke", Neurol Int Open, 1, pp.E287~E293 (2017)
- Yin J, "Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack", J Am Heart Assoc, 4, pp.e002699~ (2015)
- Xia GH, "Stroke dysbiosis index(SDI)in gut microbiome are associated with brain injury and prognosis of stroke", Front Neurol, 10, pp.397~ (2019)
- Chen Y, "Persistence of gut microbiota dysbiosis and chronic systemic inflammation after cerebral infarction in cynomolgus monkeys", Front Neurol, 10, pp.661~ (2019)
- Singh V, "Microbiota dysbiosis controls the neuroinflammatory response after stroke", J Neurosci, 36, pp.7428~7440 (2016)
- Peh A, "Gut microbiota and their metabolites in stroke : a double-edged sword", Stroke, 53, pp.1788~1801 (2022)
- Lawlor DA, "Mendelian randomization : using genes as instruments for making causal inferences in epidemiology", Stat Med, 27, pp.1133~1163 (2008)
- Sanna S, "Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases", Nat Genet, 51, pp.600~605 (2019)
- Skrivankova VW, "Strengthening the reporting of observational studies in epidemiology using Mendelian randomization : the STROBE-MR statement", JAMA, 326, pp.1614~1621 (2021)
- Kurilshikov A, "Large-scale association analyses identify host factors influencing human gut microbiome composition", Nat Genet, 53, pp.156~165 (2021)
- Zhou W, "Global Biobank Meta-analysis Initiative : powering genetic discovery across human disease", Cell Genom, 2, pp.100192~ (2022)
- Julkunen H, "Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank", Nat Commun, 14, pp.604~ (2023)
- Liu X, "Mendelian randomization analyses support causal relationships between blood metabolites and the gut microbiome", Nat Genet, 54, pp.52~61 (2022)
- Sudmant PH, "An integrated map of structural variation in 2,504 human genomes", Nature, 526, pp.75~81 (2015)
- Burgess S, "Avoiding bias from weak instruments in Mendelian randomization studies", Int J Epidemiol, 40, pp.755~764 (2011)
- Burgess S, "A review of instrumental variable estimators for Mendelian randomization", Stat Methods Med Res, 26, pp.2333~2355 (2017)
- Bulik-Sullivan BK, "LD score regression distinguishes confounding from polygenicity in genome-wide association studies", Nat Genet, 47, pp.291~295 (2015)
- Jia J, "Assessment of causal direction between gut microbiota-dependent metabolites and cardiometabolic health : a bidirectional Mendelian randomization analysis", Diabetes, 68, pp.1747~1755 (2019)
- Fu J, "The gut microbiome contributes to a substantial proportion of the variation in blood lipids", Circ Res, 117, pp.817~824 (2015)
- Hindy G, "Role of blood lipids in the development of ischemic stroke and its subtypes : a Mendelian randomization study", Stroke, 49, pp.820~827 (2018)
- Burgess S, "Network Mendelian randomization : using genetic variants as instrumental variables to investigate mediation in causal pathways", Int J Epidemiol, 44, pp.484~495 (2015)
- Sanderson E, "Multivariable Mendelian randomization and mediation", Cold Spring Harb Perspect Med, 11, pp.a038984~ (2021)
- Burgess S, "Multivariable Mendelian randomization : the use of pleiotropic genetic variants to estimate causal effects", Am J Epidemiol, 181, pp.251~260 (2015)
- Bowden J, "Mendelian randomization with invalid instruments : effect estimation and bias detection through Egger regression", Int J Epidemiol, 44, pp.512~525 (2015)
- Hemani G, "The MR-Base platform supports systematic causal inference across the human phenome", Elife, 7, pp.e34408~ (2018)
- Benjamini Y, "Controlling the false discovery rate : a practical and powerful approach to multiple testing", J R Stat Soc Series B(Methodol), 57, pp.289~300 (1995)
- Nan Xu, "Astragaloside IV reversed the autophagy and oxidative stress induced by the intestinal microbiota of AIS in mice", The Journal of Microbiology, 56(11), pp.838~846 (2018), 한국미생물학회[DOI]
- Chen YR, "Desulfovibrio is not always associated with adverse health effects in the Guangdong Gut Microbiome Project", PeerJ, 9, pp.e12033~ (2021)
- Mitsuoka T, "Bifidobacteria and their role in human health", J Ind Microbiol, 6, pp.263~267 (1990)
- Koskinen TT, "Intake of fermented and non-fermented dairy products and risk of incident CHD : the Kuopio Ischaemic Heart Disease Risk Factor Study", Br J Nutr, 120, pp.1288~1297 (2018)
- Li H, "Dysbiosis characteristics of gut microbiota in cerebral infarction patients", Transl Neurosci, 11, pp.124~133 (2020)
- Liu Y, "The association of post-stroke cognitive impairment and gut microbiota and its corresponding metabolites", J Alzheimers Dis, 73, pp.1455~1466 (2020)
- Dang Y, "Distinctive gut microbiota alteration is associated with poststroke functional recovery : results from a prospective cohort study", Neural Plast, 2021, pp.1469339~ (2021)
- O’Donnell MJ, "Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries(INTERSTROKE) : a case-control study", Lancet, 388, pp.761~775 (2016)
- Meikle PJ, "HDL phospholipids, but not cholesterol distinguish acute coronary syndrome from stable coronary artery disease", J Am Heart Assoc, 8, pp.e011792~ (2019)
- Yun KE, "Major lipids, apolipoproteins, and alterations of gut microbiota", J Clin Med, 9, pp.1589~ (2020)
- Yiu JHC, "Gut microbiota-associated activation of TLR5 induces apolipoprotein A1 production in the liver", Circ Res, 127, pp.1236~1252 (2020)
- Rühlemann MC, "Genome-wide association study in 8,956German individuals identifies influence of ABO histo-blood groups on gut microbiome", Nat Genet, 53, pp.147~155 (2021)
- Faust K, "Microbial interactions : from networks to models", Nat Rev Microbiol, 10, pp.538~550 (2012)
- Davey Smith G, "Mendelian randomization : genetic anchors for causal inference in epidemiological studies", Hum Mol Genet, 23(R1), pp.R89~R98 (2014)